You are currently viewing a new version of our website. To view the old version click .

In Vitro Cell Models in Regenerative Medicine

This special issue belongs to the section “Pharmaceutical Technology, Manufacturing and Devices“.

Special Issue Information

Dear Colleagues,

We are pleased to announce the new Special Issue for Pharmaceutics entitled "In Vitro Cell Models in Regenerative Medicine".

Due to the constant requirement for the reduction in animal use in research, the need for development of adequate alternative testing systems is rapidly arising. The most challenging step in the creation of an ideal in vitro system is mimicking the tissue environment in an appropriate way. Three-dimensional cell models are slowly overcoming traditional two-dimensional cultures, while organ-on-chip systems are introducing a real revolution in in vitro testing.

This Special Issue on "In Vitro Cell Models in Regenerative Medicine" encourages authors to submit their original research or review articles that bring new methods, solutions, and models for regenerative medicine and pharmaceutical purposes. Topics include but are not limited to biocompatibility testing in vitro, stem cells, 2D and 3D cell cultures, in vitro cell models for soft and hard tissue regeneration, in vitro cell models for testing drugs and medical devices for application in regenerative medicine, personalized in vitro cell models, matrices and scaffolds for 3D cell models, biomaterials, 3D printing, bioreactors, and pharmaceutics in regenerative medicine.

Dr. Sanja Stojanović
Prof. Dr. Stevo Najman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • in vitro testing
  • in vitro cell models
  • cell culture methods
  • biocompatibility in vitro
  • stem cells
  • 2D and 3D cell models
  • bioreactors
  • organ-on-chip
  • biomaterials

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923